14G2a anti-GD2 crossreactivity with the CD166 antigen.
Agrawal
Vaidehi
V
Frankel
Arthur Edward
AE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000378:metabolism*; D015703:Antigens, CD / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D015816:Cell Adhesion Molecules, Neuronal / Q000276:immunology; D002469:Cell Separation; D002986:Clinical Trials as Topic; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D005326:Fetal Proteins / Q000276:immunology; D005434:Flow Cytometry; D005732:Gangliosides / Q000276:immunology; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D017599:Neuroectodermal Tumors / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000378:metabolism*; D020410:Activated-Leukocyte Cell Adhesion Molecule
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D015816:Cell Adhesion Molecules, Neuronal; D005326:Fetal Proteins; D005732:Gangliosides; D011993:Recombinant Fusion Proteins; C105613:ALCAM protein, human; D020410:Activated-Leukocyte Cell Adhesion Molecule; C025447:sialogangliosides